Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

Bookmark and Share

17th ECCO - 38th ESMO - 32nd ESTRO European Cancer Congress (ECC 2013)

27 Sep 2013
Published: 3 Oct 2013
Views: 5161
Rating:
Save
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK

Prof Jack Cuzick talks to ecancer at the 2013 European Cancer Congress in Amsterdam about the role of prostate cancer screening and why two trials, European Randomized Study of Screening for Prostate Cancer (ERSPC) and the PLCO trial, came to different conclusions about its benefits.

Related Videos

Digital rectal examination is not useful as a solitary screening tool for...
Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023
Single intensive screening intervention using PSA and Stockholm3 in combination...
Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )
16 Mar 2023
Navigating evidence-based care with limited resources in Africa
Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine...
Navigating evidence-based care with limited resources in Africa ( Dr Verna Vanderpuye - National center for Radiotherapy and Nuclear Medicine, Accra, Ghana )
6 Feb 2023
Assessment of cervical and breast cancer screening in Latin America and...
Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project ( Dr Isabel Mosquera - International Agency for Research on Cancer, Lyon, France )
21 Nov 2022
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
Intraoperative Radiotherapy ( Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal )
25 Sep 2022
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer
Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike...
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer ( Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike Schlürmann )
11 Sep 2022
Prostate cancer screening: A novel risk prediction tool with standard biopsies...
Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden
Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies ( Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden )
20 Jul 2022
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation